Cognition Therapeutics (CGTX) AGM 2026 summary

Opening remarks and agenda

• Meeting officially called to order and held in an all-virtual format to maximize stockholder participation.

• Directors, executive officers, and representatives from the independent accounting firm introduced.

• Rules of conduct and procedures for participation and voting explained, with emphasis on orderly conduct and agenda-focused questions.

• Notice of meeting and quorum confirmed, with voting procedures outlined for stockholders.

Board and executive committee updates

• Board members and executive officers present, including chairs of audit, compensation, and governance committees.

Shareholder proposals

• Proposal one: Election of class two directors to serve three-year terms until the 2029 annual meeting.

• Proposal two: Ratification of EY as independent registered public accounting firm for the 2026 fiscal year.